Cargando…

Prognostic factors related to the risk of COVID-19 infection in MS patients

Detalles Bibliográficos
Autores principales:	Montini, Federico, Nozzolillo, Agostino, Moiola, Lucia, Rocca, Maria, Martinelli, Vittorio, Filippi, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498379/ http://dx.doi.org/10.1016/j.jns.2021.118236

Ejemplares similares

Modifiable risk factors of COVID-19 in patients with multiple sclerosis: a single-centre case–control study
por: Montini, Federico, et al.
Publicado: (2023)

COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
por: Preziosa, Paolo, et al.
Publicado: (2020)

Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?
por: Orrico, Mario, et al.
Publicado: (2021)

Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study
por: Zanetta, Chiara, et al.
Publicado: (2023)

Correction to: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study
por: Zanetta, Chiara, et al.
Publicado: (2023)

Serological response to SARS-CoV-2 vaccination in multiple sclerosis patients treated with fingolimod or ocrelizumab: an initial real-life experience
por: S., Guerrieri, et al.
Publicado: (2021)

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (clippers) after COVID-19
por: Montini, Federico, et al.
Publicado: (2021)

Stress related to COVID-19 pandemic as a trigger for disease activity in multiple sclerosis: a case report
por: Giordano, Antonino, et al.
Publicado: (2021)

Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) after SARS-CoV-2 pneumonia
por: Montini, Federico, et al.
Publicado: (2021)

Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis
por: Sorosina, Melissa, et al.
Publicado: (2023)

COVID-19 with no antibody response in a multiple sclerosis patient treated with cladribine: Implication for vaccination program?
por: Gelibter, Stefano, et al.
Publicado: (2021)

Natalizumab in the pediatric MS population: results of the Italian registry
por: Ghezzi, Angelo, et al.
Publicado: (2015)

Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab
por: Diotti, Roberta Antonia, et al.
Publicado: (2016)

Safety of Natalizumab infusion in multiple sclerosis patients during active SARS-CoV-2 infection
por: Landi, Doriana, et al.
Publicado: (2022)

Role of artificial intelligence in MS clinical practice
por: Bonacchi, Raffaello, et al.
Publicado: (2022)

Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression
por: Preziosa, Paolo, et al.
Publicado: (2022)

Dysregulation of MS risk genes and pathways at distinct stages of disease
por: Srinivasan, Sundararajan, et al.
Publicado: (2017)

Prognostic value of serum neurofilaments in patients with clinically isolated syndromes
por: Dalla Costa, Gloria, et al.
Publicado: (2019)

Physical Exercise Moderates the Effects of Disability on Depression in People with Multiple Sclerosis during the COVID-19 Outbreak
por: Carotenuto, Antonio, et al.
Publicado: (2021)

Impact of MS genetic loci on familial aggregation, clinical phenotype, and disease prediction
por: Esposito, Federica, et al.
Publicado: (2015)

Time-varying connectivity of the precuneus and its association with cognition and depressive symptoms in neuromyelitis optica: A pilot MRI study
por: Cacciaguerra, Laura, et al.
Publicado: (2022)

Abnormalities of Resting State Functional Connectivity Are Related to Sustained Attention Deficits in MS
por: Loitfelder, Marisa, et al.
Publicado: (2012)

Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis
por: Passerini, Gabriella, et al.
Publicado: (2016)

Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine Approach
por: Ferrè, Laura, et al.
Publicado: (2023)

Incidence and Predictive Risk Factors of Infective Events in Patients With Multiple Sclerosis Treated With Agents Targeting CD20 and CD52 Surface Antigens
por: Zappulo, Emanuela, et al.
Publicado: (2019)

Magnetic Resonance Imaging Evaluation of Perivascular Space Abnormalities in Neuromyelitis Optica
por: Cacciaguerra, Laura, et al.
Publicado: (2022)

The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective
por: Messina, Maria Josè, et al.
Publicado: (2015)

Changes in cortical motor outputs after a motor relapse of multiple sclerosis
por: Chieffo, Raffaella, et al.
Publicado: (2019)

Successful treatment of HIV-associated tumefactive demyelinating lesions with corticosteroids and cyclophosphamide: a case report
por: Lazzarin, Serena Marita, et al.
Publicado: (2020)

Loss of Circulating CD8+ CD161(high) T Cells in Primary Progressive Multiple Sclerosis
por: Acquaviva, Massimo, et al.
Publicado: (2019)

In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis
por: Vabanesi, Marco, et al.
Publicado: (2019)

Inferring Multiple Sclerosis Stages from the Blood Transcriptome via Machine Learning
por: Acquaviva, Massimo, et al.
Publicado: (2020)

Sexual Dysfunction in People with Multiple Sclerosis: The Role of Disease Severity, Illness Perception, and Depression
por: Scandurra, Cristiano, et al.
Publicado: (2023)

Prognostic Factors of MS Conversion in Optic Neuritis
por: Fajardo, Marytery, et al.
Publicado: (2015)

Cross-sectional study of smoking exposure: no differential effect on OCT metrics in a cohort of MS patients
por: Rosso, Mattia, et al.
Publicado: (2019)

The impact of the COVID-19 pandemic on an international rehabilitation study in MS: the CogEx experience
por: Feinstein, Anthony, et al.
Publicado: (2021)

Acute Disseminated Encephalomyelitis
por: Filippi, Massimo, et al.
Publicado: (2020)

MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies
por: De Stefano, Nicola, et al.
Publicado: (2022)

Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets
por: Moiola, Lucia, et al.
Publicado: (2022)

Discovering functional connectivity features characterizing multiple sclerosis phenotypes using explainable artificial intelligence
por: Yamin, Muhammad Abubakar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_14s3ns9g2ovfdse30td177ndos